We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Ground Broken in Human MRI Technology

By HospiMedica International staff writers
Posted on 04 Jun 2009
In a scientific development set to benefit sufferers of respiratory diseases, Australian researchers have pioneered a new imaging approach. More...


A group of scientists from the Center for Magnetic Resonance and the department of physics at the University of Queensland (UQ; Brisbane Australia) have successfully developed Australia's first hyperpolarized helium gas for use in human magnetic resonance imaging (MRI) scans. Dr. Marlies Friese reported that the UQ team recently produced sufficient gas for a human subject to inhale, and created an image of the person's airways.

According to Dr. Friese, the team had previously performed similar experiments using hyperpolarized helium imported from Germany. "The gas is helium-3, it is inert, is not radioactive, and does not react with the body so it is safe to inhale. This type of image is useful because we can obtain data on gas flow and breathing--we are the first group in Australia to achieve this. It can show how gases flow in the lung, and whether regions of the lung are ventilated normally, abnormally or not at all. Now we are able to use our locally produced gas, the technology will become more accessible to local researchers and for research of diseases such as asthma and COPD [chronic obstructive pulmonary disease].”

Dr. Friese noted that when imaging the lung or other areas where the water content was low, conventional MRI had proved inadequate. "Hyperpolarized helium MRI uses a special technique through which the nuclear magnetic moments of helium atoms are aligned so that MRI signals are enhanced by up to six orders of magnitude,” she said. "The hyperpolarized effect is relatively short lived--it lasts up to 80 hours depending on how the gas is stored and transported, with the effectiveness decreasing during that time.”

Dr. Friese reported that transport from overseas facilities was costly and difficult as transport delays can render the gas useless. The gas was produced in the HP helium laboratory at UQ, which is the only one of its kind in Australia and was supported by a UQ internal infrastructure grant. The lab was set-up through collaborations with Prof. Brian Saam of the University of Utah (Salt Lake City, USA). The facility conducts respiratory research using animal models of disease; however, interest from medical researchers recently directed the team's efforts towards human imaging.

In the future, the method could potentially be used for diagnosis and monitoring of respiratory disease within a clinical setting, according to the investigators.

Related Links:

University of Queensland



Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Patient Monitoring System
AlarmSense
Syringe Pump
SP50 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.